In humans, CYLD mono-allelic mutations underlie cutaneous tumour predisposition syndromes and somatic CYLD mutations have been linked to human papillomavirus-associated head and neck cancer [46, 47], whereas germline mutations in SPATA2 have not been described. This evidence concerns the gene CYLD and head and neck cancer.